Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative drugs work by mimicking the inherent actions of GLP-1, a hormone produced by the gut in https://bookmarkbirth.com/story21302985/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes